Last reviewed · How we verify
Placebo to match budesonide/formoterol
Placebo to match budesonide/formoterol is a Small molecule drug developed by GlaxoSmithKline. It is currently FDA-approved for Clinical trial comparator for budesonide/formoterol in asthma and COPD studies.
This is an inert placebo formulation designed to match the physical and sensory characteristics of budesonide/formoterol inhaler for blinded clinical trial purposes.
This is an inert placebo formulation designed to match the physical and sensory characteristics of budesonide/formoterol inhaler for blinded clinical trial purposes. Used for Clinical trial comparator for budesonide/formoterol in asthma and COPD studies.
At a glance
| Generic name | Placebo to match budesonide/formoterol |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Mechanism of action
Placebos are inactive substances used in controlled clinical trials to serve as a comparator arm and eliminate bias. This particular placebo is manufactured to match the appearance, taste, feel, and delivery mechanism of the active budesonide/formoterol combination inhaler, ensuring that trial participants cannot distinguish between active and placebo treatments. It contains no active pharmaceutical ingredients and produces no therapeutic effect.
Approved indications
- Clinical trial comparator for budesonide/formoterol in asthma and COPD studies
Common side effects
Key clinical trials
- A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation (PHASE4)
- Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients (PHASE2)
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE4)
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE4)
- Phase IV O2 Consumption Study in COPD Patients. (PHASE4)
- A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE3)
- A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE4)
- Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo to match budesonide/formoterol CI brief — competitive landscape report
- Placebo to match budesonide/formoterol updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about Placebo to match budesonide/formoterol
What is Placebo to match budesonide/formoterol?
How does Placebo to match budesonide/formoterol work?
What is Placebo to match budesonide/formoterol used for?
Who makes Placebo to match budesonide/formoterol?
What development phase is Placebo to match budesonide/formoterol in?
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Therapeutic area: All drugs in Respiratory
- Indication: Drugs for Clinical trial comparator for budesonide/formoterol in asthma and COPD studies
- Compare: Placebo to match budesonide/formoterol vs similar drugs
- Pricing: Placebo to match budesonide/formoterol cost, discount & access